Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
Titel:
Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
Auteur:
Denis-Bacelar, Ana M. Chittenden, Sarah J. Dearnaley, David P. Divoli, Antigoni O’Sullivan, Joe M. McCready, V. Ralph Johnson, Bernadette Du, Yong Flux, Glenn D.
Verschenen in:
European journal of nuclear medicine and molecular imaging